$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] Mechanism of action of vaccine therapy in murine hepatitis B virus carriers: vaccine-induced activation of antigen presenting dendritic cells

Journal of hepatology : the journal of the European Association for the Study of the Liver, v.30 no.5, 1999년, pp.755 - 764  

Akbar, Sk.Md.Fazle (Sk. Md. Fazle Akbar, Third Department of Internal Medicine, Ehime University School of Medicine, Shigenobu-Cho, Ehime 791-0295, Japan. Tel: 81 89 960 5308. Fax: 81 89 960 5310.) ,  Abe, Masanori (Third Department of Internal Medicine, Ehime University School of Medicine, Ehime, Japan) ,  Masumoto, Toshikazu (Third Department of Internal Medicine, Ehime University School of Medicine, Ehime, Japan) ,  Horiike, Norio (Third Department of Internal Medicine, Ehime University School of Medicine, Ehime, Japan) ,  Onji, Morikazu (Third Department of Internal Medicine, Ehime University School of Medicine, Ehime, Japan)

Abstract AI-Helper 아이콘AI-Helper

AbstractBackground/Aims: Vaccine therapy in which vaccine containing hepatitis B surface antigen (HBsAg) is injected has shown therapeutic activity (vaccine therapy) in some human and murine chronic hepatitis B virus (HBV)-carriers. Using HBV-transgenic mice (HBV-Tg), an animal model of the HBV-carr...

주제어

참고문헌 (33)

  1. Ann Intern Med Bloom 118 298 1993 10.7326/0003-4819-118-4-199302150-00009 A reappraisal of hepatitis B virus vaccination strategies using costeffectiveness analysis 

  2. Hepatology Peters 13 977 1991 10.1002/hep.1840130529 Immunology and the liver 

  3. Annu Rev Immunol Sherker 45 475 1991 Hepadnavirus and hepatocellular carcinoma 

  4. Periollo 616 1991 Viral Hepatitis and Liver Disease Treatment of chronic hepatitis B 

  5. Antiviral Chem Chemother Shaw 7 53 1996 10.1177/095632029600700201 New approaches for antiviral chemotherapy 

  6. Vaccine Burke 11 883 1993 10.1016/0264-410X(93)90374-7 Vaccine therapy for HIV, a historic view of the treatment of infectious diseases by active specific immunization with microbe-derived antigens 

  7. J Infect Dis Stanberry 155 914 1987 10.1093/infdis/155.5.914 Vaccination with herpes simplex virus glycoproteins; protection against initial and recurrent genital herpes 

  8. Trop Geogr Med Stanford 46 93 1994 The history and future of vaccination and immunotherapy for leprosy 

  9. Biomed Pharmacother Pol 49 105 1995 10.1016/0753-3322(96)82602-3 Immunotherapy of chronic hepatitis B by anti HBV vaccine 

  10. Lancet Pol 344 342 1994 10.1016/S0140-6736(94)91384-6 Specific vaccine therapy in chronic hepatitis B infection 

  11. Lancet Wen 345 1575 1995 10.1016/S0140-6736(95)91126-X Hepatitis B vaccine and anti-HBs complex as approach for vaccine therapy 

  12. J Clin Invest Vitiello 95 341 1995 10.1172/JCI117662 Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. 1. Induction of a primary cytotoxic T lymphocyte response in humans 

  13. Proc Natl Acad Sci USA Araki 86 207 1989 10.1073/pnas.86.1.207 Expression and replication of hepatitis B virus genome in transgenic mice 

  14. J Hepatol Akbar 26 131 1997 10.1016/S0168-8278(97)80019-0 Placebo-controlled trial of vaccination with hepatitis B virus surface antigen in hepatitis B virus transgenic mice 

  15. Immunology Akbar 78 468 1993 Low responsiveness of hepatitis B virus transgenic mice in antibody response to T-cell-dependent antigen: defect in antigen-presenting activity of dendritic cells 

  16. Immunology Akbar 87 519 1996 10.1046/j.1365-2567.1996.516576.x Upregulation of MHC class II antigen on dendritic cells from hepatitis B virus transgenic mice: abrogation of immune response defect to a T-cell-dependent antigen 

  17. J Exp Med Metlay 171 1753 1990 10.1084/jem.171.5.1753 The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies 

  18. J Exp Med Inaba 172 631 1990 10.1084/jem.172.2.631 Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ 

  19. Cell Immunol Crowley 118 108 1989 10.1016/0008-8749(89)90361-4 The cell surface of mouse dendritic cells: FACS analyses of dendritic cells from different tissues including thymus 

  20. J Clin Invest Waters 90 2543 1992 10.1172/JCI116148 Loss of the common“A” determinant of hepatitis B surface antigen by a vaccine-induced escape mutant 

  21. Annu Rev Immunol Steinman 9 271 1991 10.1146/annurev.iy.09.040191.001415 The dendritic cell system and its role in immunogenicity 

  22. Immunology Mactonia 67 285 1989 Suppression of immune responses by dendritic cells infected with HIV. 

  23. Adv Exp Med Biol Gabrilovich 378 469 1995 10.1007/978-1-4615-1971-3_105 Defects in the function of dendritic cells in murine retroviral infection 

  24. J Exp Med Egea 173 531 1991 10.1084/jem.173.3.531 The cellular basis for lack of antibody response to hepatitis B vaccine in humans 

  25. Immunology Kurose 92 494 1997 10.1046/j.1365-2567.1997.00373.x Production of antibody to hepatitis B surface antigen (anti-HBs) by murine hepatitis B virus carriers: neonatal tolerance versus antigen presentation by dendritic cells 

  26. Annu Rev Immunol Matzinger 12 991 1994 10.1146/annurev.iy.12.040194.005015 Tolerance, danger and extended family 

  27. Science Ridge 271 1723 1996 10.1126/science.271.5256.1723 Neonatal tolerance revisited: turning on newborn T cells with dendritic cells 

  28. Hepatology Chisari 22 1316 1995 Hepatitis B virus transgenic mice: insights into the virus and disease 

  29. J Immunol Schirmbeck 152 1110 1994 10.4049/jimmunol.152.3.1110 Immunization with soluble hepatitis B virus surface protein elicits murine H-2 class I-restricted CD8+ cytotoxic T lymphocyte responses in vivo 

  30. Eur J Immunol Schirmbeck 24 1010 1994 10.1002/eji.1830240512 Selective stimulation of murine cytotoxic T cell and antibody responses by particulate or monometric hepatitis B virus surface (S) antigen 

  31. Eur J Immunol Schirmbeck-R 26 2812 1996 10.1002/eji.1830261204 “Empty” Ld molecules capture peptides from endocytosed hepatitis B surface antigen particles for major histocompatibility complex class I-restricted presentation 

  32. Immunology Akbar 1998 Prognostic importance of antigen presenting dendritic cells during vaccine therapy in hepatitis B virus transgenic mice 

  33. Adv Exp Med Biol Bergstresser 417 65 1997 10.1007/978-1-4757-9966-8_11 T cell-mediated terminal maturation of dendritic cells 

관련 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로